Home › Funds › DIADEMA PARTNERS LP › CRBP
DIADEMA PARTNERS LP position in CRBP
CORBUS PHARMACEUTICALS · Health Care
DIADEMA PARTNERS LP reported holding 301,264 shares of CRBP (CORBUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 0.61% of its reported portfolio and ranking #38 among its reported holdings. DIADEMA PARTNERS LP has disclosed CRBP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's CRBP position evolved
DIADEMA PARTNERS LP first disclosed a stake in CRBP in Q1 2026 at 115,300 shares (US$1.1M). The position peaked in Q2 2026 at 301,264 shares, worth US$2.8M. Across 2 filings, DIADEMA PARTNERS LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 301,264 shares valued at US$2.8M — an increase of 185,964 shares quarter over quarter.. Notable position changes include a 161% increase in Q2 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 115.30K | $1.08M | New |
| Q2 2026 | 301.26K | $2.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS) is a Health Care company. 24 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.1M), Prosight Management, LP (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Cormorant Asset Management, LP 2.34M sh · $22.00M · Q2 2026
- Jones Hill Capital LP 653.57K sh · $6.13M · Q2 2026
- Prosight Management, LP 650.00K sh · $6.10M · Q2 2026
- Stonepine Capital Management, LLC 425.00K sh · $3.99M · Q2 2026
- Exome Asset Management LLC 184.91K sh · $1.73M · Q2 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held CRBP?
DIADEMA PARTNERS LP has disclosed CRBP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is DIADEMA PARTNERS LP's current position in CRBP?
As of Q2 2026, DIADEMA PARTNERS LP holds 301.26K shares of CRBP (CORBUS PHARMACEUTICALS), valued at $2.83M, representing 0.61% of its reported portfolio and ranking #38.
Has DIADEMA PARTNERS LP been buying or selling CRBP?
In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP increased its position in CRBP. The position peaked in Q2 2026 at 301.26K shares.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, Prosight Management, LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.